Cervical Cancer Screening Market: Projected to Exceed $34.92B by 2028, Catalyzed by the rise in awareness about cervical cancer prevention and the availability of advanced screening technologies
02 May, 2023

Renub Research has recently published a report titled "Cervical Cancer Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," providing a comprehensive analysis of the industry that includes market share insights. In addition, the report comprises competitor and regional research and contemporary extension. The cervical Cancer Screening Industry shall experience a CAGR of nearly 4.57% from 2022 to 2028. Cervical cancer is a significant public health concern worldwide, but it disproportionately affects women in developing countries.

Cervical cancer screening, which typically involves cervical cytology or HPV testing, is crucial in detecting cell changes that could potentially lead to cancer. The availability of this non-invasive procedure in a doctor's office or clinic, combined with personalized screening recommendations based on individual risk factors, has led to increasing awareness and education about cervical cancer prevention. Early detection of abnormalities in the cervix cells before they develop into cancer allows for early intervention and treatment, improving treatment outcomes. In addition, regular screening has significantly decreased the risk of developing cervical cancer, making it a cost-effective and valuable tool in preventing and detecting this disease.

Cervical cancer is rated as the fourth most common cancer among women by the World Health Organization, and 99% of cervical cancer cases are associated with high-risk strains of human papillomavirus (HPV) acquired through sexual contact. In February 2022, they also reported that there were 604,000 new cases of cervical cancer in women globally, resulting in 342,000 fatalities.

The cervical cancer screening market has experienced growth due to a couple of factors, including increased awareness and education about cervical cancer prevention and the availability of advanced screening technologies. These factors have led to a greater demand for cervical cancer screening services and products and increased investment in research and development of new screening technologies. Additionally, government initiatives and public health campaigns aimed at raising awareness about the importance of cervical cancer screening have contributed to the market's growth.

In recent years the demand for HPV DNA Test screening has increased in the Cervical Cancer Screening Market

The growth of HPV DNA test screening in the cervical cancer screening market is due to the high accuracy of these tests compared to traditional Pap smear tests, leading to increased adoption by healthcare providers and patients. Additionally, new technologies have made screening more accessible, while increased awareness and education about the link between HPV and cervical cancer have created greater demand for testing. Finally, including HPV DNA testing in national screening guidelines has further driven the growth of cervical cancer screenings.

However, Pap smear testing dominates cervical cancer screening market due to its wide availability and use over time, low cost and simplicity, proven success in reducing cervical cancer incidence through early detection and treatment of abnormal cells, and inclusion in national screening guidelines and recommendations for many years.

Government Policies contribute to the Increasing demand for Cervical Cancer Screening in the United States

Cervical cancer is one of the leading reasons of mortalities among women in the United States, with about 14,100 women diagnosed with invasive cervical cancer, according to Cervical Cancer Statistics. However, advancements in screening technologies such as liquid-based cytology and HPV testing have improved the precision and advantages of cervical cancer screening in the United States.

Favourable government policies influence the United States' cervical cancer screening. Moreover, the designation of January as Cervical Health Awareness Month by the United States Congress highlights the significance of cervical cancer screening, which contributes to the cervical cancer screening market growth.

Report Details:

Competitive Landscape

Abbott Laboratories, Becton, Siemens AG, Quest Diagnostics, Roche, Hologic Corporation, and Cardinal Health are among the major companies in the cervical cancer screening market.

The cervical cancer screening market is highly competitive, driven by rising incidence and awareness of early detection. Advanced screening technologies like liquid-based cytology and HPV DNA testing have improved accuracy, leading to more investment in R&D. The market has many players, and new entrants face intense competition. Companies expand portfolios, develop new technologies, and improve marketing to gain market share. Government policies, regulations, and reimbursement policies shape the market, impacting growth and attracting new entrants. In addition, reimbursement policies affect screening service adoption by healthcare providers and patients.

Market Summary:

Type - The Report covers cervical cancer screening market, by type in 3 viewpoints

•    Pap Smear Tests Market
•    HPV DNA Tests Market
•    VIA Tests Market

Country - By country, the cervical cancer screening market, breakup in 20 viewpoints

•    United Kingdom
•    France
•    Germany
•    Italy
•    Spain
•    Sweden
•    Switzerland
•    Norway
•    Netherlands
•    United States
•    Canada
•    Japan
•    Korea
•    Singapore
•    Malaysia
•    India
•    China
•    Indonesia
•    Thailand
•    Rest of World

Key Players- All the major players of the cervical cancer screening market have been covered from 3 Viewpoints (Overview, Initiatives and Recent Developments, and Sales)

•    Abbott Laboratories
•    Becton
•    Siemens AG
•    Quest Diagnostics
•    Roche
•    Hologic Corporation
•    Cardinal Health
 

About Us
Renub Research is a Market Research and Consulting Company. We have more than 14 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us
Renub Research
Phone: +1-478-202-3244 (USA) | +91-120-421-9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research